Los puntos clave no están disponibles para este artículo en este momento.
Based on this in silico and in vitro evidence, we propose CO-MT as a promising antiviral medicine candidate for treating COVID-19. In vivo investigation is required to clarify the therapeutic potential of CO-MT in COVID-19.
Arumugam et al. (Wed,) studied this question.